[SYRS] QoQ Quarter Result on 31-Dec-2021 [#Q4]

Stock
[SYRS] Syros Pharmaceuticals, Inc.
Announcement Date
15-Mar-2022
Financial Year
2021
Quarter
31-Dec-2021 [#Q4]
Profit Trend
QoQ- 8.51%
YoY- 20.97%
Quarter Report
SYRS's Result
SYRS's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Revenue 3,891 6,276 5,467 7,802 5,697 5,162 4,827 -13.37%
PBT -30,253 -34,481 -25,146 -23,813 -26,027 -22,490 -14,228 65.27%
Tax -9,201 712 -1,507 986 984 969 967 -
NP -21,052 -35,193 -23,639 -23,813 -26,027 -22,490 -14,228 29.81%
Tax Rate - - - - - - - -
Total Cost 24,943 41,469 29,106 31,615 31,724 27,652 19,055 19.64%
Ratio Analysis
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
NP Margin -541.04 -560.76 -432.39 -305.22 -456.85 -435.68 -294.76 49.85%
Per Share
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
EPS -2.24 -5.51 -3.75 -3.78 -4.14 -3.60 -2.32 -2.31%
EPS Diluted -2.24 -5.51 -3.75 -3.78 -4.14 -3.58 -2.32 -2.31%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.